INDUSTRIALISATION
INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
Subscribe
INDUSTRIALISATION
INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
SEARCH
SEARCH
advanced search
ORAL DRUG DELIVERY
161
Issue No #161
June 17th, 2024
Download PDF
Issue 161 - MayJun 2024
Inside the magazine
GI/ORAL
Lucia Gurruchaga
Qualicaps
NAVIGATING THE TRANSITION: EXPLORING ALTERNATIVES TO TiO
2
IN PHARMACEUTICAL FORMULATIONS
Lucía Gurruchaga discusses the push to develop an alternative opacifier and white colourant to titanium dioxide in the wake of the European Commission’s announcement that the additive may be banned in medicinal products, presenting data from recent testing on Qualicaps’ own novel alternative.
GI/ORAL
Ivy Comer
Aptar CSP Technologies
TARGETING NITROSAMINE PRECURSORS WITH NOVEL ACTIVE MATERIAL SCIENCE SCAVENGER TECHNOLOGIES
Ivy Comer, Amanda Murph and Jason Pratt, discuss the challenges in combatting N-nitrosamine formation in oral solid dosage forms, and present Aptar’s 3-Phase Activ-Polymer technology as a novel packaging-based solution.
EARLY INSIGHT
Dr Buddhadev Chaudhuri
Keylika
TACKLING IRON-DEFICIENCY ANAEMIA: A LEAP FORWARD WITH A REVOLUTIONARY BUCCAL PATCH
Buddhadev P Chaudhuri and Frederik Ceyssens, discuss the challenges of iron-deficiency anaemia and introduce Keylika’s new buccal patch for iron delivery.
EXPERT VIEW
Jason Hunt
ADAPTING TO AN AGEING WORLD: FORMULATION STRATEGIES TO BOOST PATIENT COMPLIANCE
Jason Hunt and Yeli Zhang discuss the key factors undermining patient compliance in older adults and explore how the pharmaceutical industry can leverage excipients to enhance drug formulations and improve medication compliance among this critical demographic.
EXPERT VIEW
Nigel Theobald
ARE ORAL FORMULATIONS OF OLIGONUCLEOTIDE THERAPEUTICS WITHIN REACH?
Nigel Theobald, discusses key issues and strategies for formulation scientists aiming to unlock the potential of oral delivery for small interfering ribonucleic acid drugs targeted against gastrointestinal diseases and cancers.
EXPERT VIEW
Mariona Venceslao Molins
DIFFERENTIATING ORAL SUSPENSIONS WITH VERSATILE EXCIPIENTS
Mariona Venceslao Molins and Liliana Miinea discuss how excipient-based approaches can facilitate patient-centric formulations and transform oral suspensions.
EXPERT VIEW
Dr Jnanadeva Bhat
STRATEGIES TO MITIGATE GELATIN CROSS-LINKING IN ORAL SOLID DRUG DELIVERY
Jnanadeva Bhat and Manali Dalvi discuss the factors contributing to gelatin cross-linking in oral solid dose delivery – and strategies to tackle the resulting challenges.
EXPERT VIEW
Dr Zdravka Misic
CANNABIDIOL DELIVERY THAT IS ON THE “TIP OF THE TONGUE”
Zdravka Misic explores how formulation expertise can be applied to overcome the low bioavailability of cannabinoids and how innovation in orally disintegrating tablets is driving progress for cannabidiol-based therapeutics.
Top
